• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
WANG Ying.Preliminary study on the application of digital medical supervision principle in software as a medical device in China[J].Journal Of Pharmaceutical Research,2024,43(4):359-365,395[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2574times   Download 2636次 QR Code for this article
Scan with your phone!
我国数字医疗监管原则在独立软件医疗器械的应用初探
王颖
Font:Larger+|Default|Smaller-
(上海市药品和医疗器械不良反应监测中心,上海 200040)
摘要:
新兴技术的发展,推动数字疗法逐渐流行,软件已成为医疗产品的重要组成部分。具有诊断、预防、治疗等功能的软件(Software as a Medical Device,SaMD)作为医疗器械软件的子集,亦属于数字医疗范畴,但由于国内外尚无对其完整全面的评估与监管体系,其监管问题亟需加强监管研究。本文通过介绍SaMD相关概念及政策、人工智能背景下SaMD面临的监管挑战、我国和WHO对数字医疗的管理原则等情况,使读者获悉为加强SaMD审评与监管的思路,以期对完善我国SaMD监管原则提供启示。
关键词:  数字健康  监管框架  监管原则  医疗器械  独立软件
DOI:10.13506/j.cnki.jpr.2024.04.009
基金项目:
Publication Date:April 25, 2024
Preliminary study on the application of digital medical supervision principle in software as a medical device in China
WANG Ying
(Shanghai Center for Adverse Drug and Medical Device Reaction Monitoring, Shanghai 200040, China)
Abstract:
The development of emerging technologies has promoted the popularity of digital therapy, and software has become an important part of medical products. Software as a Medical Device (SaMD) with the functions of diagnosis, prevention and treatment, as a subset of medical device software, also belongs to the category of digital medical care. However, due to the lack of a complete and comprehensive evaluation and supervision system at home and abroad, it is urgent to strengthen supervision research on its supervision. This paper introduces the related concepts and policies of SaMD, the regulatory challenges faced by SaMD under the background of artificial intelligence, and the management principles of digital medical care in China and WHO, so as to inform readers of the ideas for strengthening the review and supervision of SaMD, with a view to providing enlightenment for improving the regulatory principles of SaMD in China.
Key words:  Digital health  Regulatory framework  Regulatory principles  Software as a Medical Device
Today's Visits:487    Total Visits:2383201
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.